Release Date: 08/11/11 18:33 Summary: Atlas 2011 Annual General Meeting presentation Price Sensitive: No Download Document 2.62MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%